- Home
- EOSE vs BME Comparison
EOSE vs BME Comparison
Compare EOSE & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSE
- BME
- Stock Information
- Founded
- EOSE 2008
- BME 2005
- Country
- EOSE United States
- BME United States
- Employees
- EOSE N/A
- BME N/A
- Industry
- EOSE Industrial Machinery/Components
- BME Trusts Except Educational Religious and Charitable
- Sector
- EOSE Miscellaneous
- BME Finance
- Exchange
- EOSE Nasdaq
- BME Nasdaq
- Market Cap
- EOSE 542.2M
- BME 525.3M
- IPO Year
- EOSE N/A
- BME N/A
- Fundamental
- Price
- EOSE $2.19
- BME $38.44
- Analyst Decision
- EOSE Strong Buy
- BME
- Analyst Count
- EOSE 6
- BME 0
- Target Price
- EOSE $5.42
- BME N/A
- AVG Volume (30 Days)
- EOSE 7.5M
- BME 34.0K
- Earning Date
- EOSE 11-05-2024
- BME 01-01-0001
- Dividend Yield
- EOSE N/A
- BME 6.26%
- EPS Growth
- EOSE N/A
- BME N/A
- EPS
- EOSE N/A
- BME 1.44
- Revenue
- EOSE $14,963,000.00
- BME N/A
- Revenue This Year
- EOSE $187.90
- BME N/A
- Revenue Next Year
- EOSE $391.53
- BME N/A
- P/E Ratio
- EOSE N/A
- BME $28.37
- Revenue Growth
- EOSE 20.34
- BME N/A
- 52 Week Low
- EOSE $0.61
- BME $35.53
- 52 Week High
- EOSE $3.66
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- EOSE 33.48
- BME 25.97
- Support Level
- EOSE $2.23
- BME $39.93
- Resistance Level
- EOSE $2.52
- BME $41.36
- Average True Range (ATR)
- EOSE 0.26
- BME 0.53
- MACD
- EOSE -0.12
- BME -0.10
- Stochastic Oscillator
- EOSE 2.11
- BME 2.99
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.